Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 12 — Responsible Consumption and Production
SDG 13 — Climate Action
This track focuses on the latest innovations in pharmaceutical chemistry, including novel drug design and synthesis methodologies. Participants will explore the implications of these advancements on drug efficacy and safety.
This session will delve into the evolving role of clinical pharmacy in patient care, emphasizing evidence-based practices and patient-centered approaches. Discussions will include the impact of clinical pharmacists on healthcare outcomes and medication management.
This track addresses the latest technological advancements in laboratory medicine, including diagnostic techniques and laboratory automation. Participants will discuss the challenges faced in implementing these innovations in clinical settings.
Focusing on the bridge between laboratory research and clinical application, this session will highlight successful case studies in translational research. Attendees will examine strategies for enhancing the translation of pharmaceutical discoveries into practice.
This track will explore cutting-edge analytical techniques used in the drug development process, including high-throughput screening and mass spectrometry. Participants will discuss the importance of these methods in ensuring drug quality and safety.
This session will highlight sustainable practices within pharmacy and laboratory management, focusing on reducing environmental impact and enhancing operational efficiency. Discussions will include case studies of successful implementations in various settings.
This track will cover the critical aspects of quality control in pharmaceutical manufacturing, including regulatory compliance and risk management. Participants will discuss best practices for ensuring product integrity and patient safety.
This session will focus on innovative methodologies for assessing and enhancing drug safety throughout the product lifecycle. Participants will explore the role of pharmacovigilance and risk assessment in improving patient outcomes.
This track will examine the emerging field of molecular pharmacy, focusing on the design and application of molecularly targeted therapies. Discussions will include the implications of molecular advancements for personalized medicine.
Participants in this session will explore current trends in pharmaceutical technology, including digital health solutions and telepharmacy. The impact of these technologies on patient care and pharmacy practice will be critically analyzed.
This track will focus on innovative educational strategies in pharmacy and laboratory sciences, emphasizing the integration of technology and experiential learning. Participants will discuss the importance of preparing future professionals for the evolving healthcare landscape.
SNRI maintains uninterrupted academic processes in the current global situation. Participants can engage and publish through online and blended conference formats.
PLEASE READ: CLOSING ENABLED IN 20S